Ingevity Narrows FY26 EBITDA Guidance to $385M-$395M After Q3 Beat on Margins
NGVT sits 61% above its 52-week low of $45.85 on elevated volume (2.7× avg).
Summary
Ingevity posted Q3 net sales of $305.1 million, down 8% on the April 15 Road Markings divestiture but up 2% excluding it, with net income from continuing operations of $49.3 million, or $1.41 per diluted share, and adjusted EPS of $1.63. Adjusted EBITDA slipped $2.4 million to $108.0 million while margin expanded 230 basis points to 35.4%, helped by pricing and mix in Performance Materials and better Advanced Polymer Technologies results. Management narrowed full-year 2026 adjusted EBITDA guidance to $385 million-$395 million, holding the midpoint of the prior range, and set diluted adjusted EPS at $5.25-$5.45 with free cash flow of $220 million-$230 million excluding the $113.2 million litigation payment. The soft spot is Pavement Technologies, where segment EBITDA fell $7.3 million to $19.6 million on higher asphalt and logistics costs. The company also said the timing of an announced agreement to sell Advanced Polymer Technologies may extend into early 2027, pushing out a key portfolio catalyst. Q3 buybacks totaled roughly $39 million at a $71.45 average, leaving about $172 million on the authorization, with net leverage steady at 2.5 times. The earnings call is November 5 at 10:00 a.m. Eastern.
At the time of this announcement, NGVT was trading at $73.73 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $45.85 to $79.29. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.